PolyPhotonix

Content by PolyPhotonix:

Articles

Business & Profession Business and Innovation

In Agreement

02/07/2022 | Sponsored by PolyPhotonix

PolyPhotonix names Prevail Partners as its lead US investor whose affiliate will lead Noctura 400 FDA clinical trials

Subspecialties Retina

Saving Sight With Light

12/06/2021 | Sponsored by PolyPhotonix

Noctura 400 from PolyPhotonix offers a revolutionary, home-based non-invasive diabetic retinopathy treatment that reduces oxygen demand in the retina

Subspecialties Diabetes

Sleeping Off Diabetic Retinopathy

09/01/2021 | Sponsored by PolyPhotonix

Sharing results from a real-world single center study of patients with diabetic macular oedema (DMO) who wore a home-use sleep mask (Noctura 400)

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: